Concepedia

Gareth Rivalland

GR

13

Publications

431

Citations

12

H-Index

2010

Active since

Affiliations

Olivia Newton-John Cancer Wellness & Research Centre(Current)

Auckland City Hospital

The University of Melbourne

Shanghai Pulmonary Hospital

Austin Health

Gareth Rivalland is an author at Olivia Newton-John Cancer Wellness & Research Centre specializing in medicine, radiation oncology, and lung cancer.

Top concepts

Publications per year

2010–2022

13

Publications

13

Tislelizumab Versus Docetaxel in Patients With Previously Treated Advanced NSCLC (RATIONALE-303): A Phase 3, Open-Label, Randomized Controlled Trial

Caicun Zhou, Dingzhi Huang, Yun Fan et al. · Journal of Thoracic Oncology · 2022 · 97 citations · Full text

Pembrolizumab as Palliative Immunotherapy in Malignant Pleural Mesothelioma

Yannis Metaxas, Gareth Rivalland, Laetitia Mauti et al. · Journal of Thoracic Oncology · 2018 · 91 citations · Full text

, , +1

The immune checkpoint, HVEM may contribute to immune escape in non-small cell lung cancer lacking PD-L1 expression

Shengxiang Ren, Qinrui Tian, Nadav Amar et al. · Lung Cancer · 2018 · 50 citations

, , +8

NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer

José Luis Leal, Geoffrey Peters, Marcin Szaumkessel et al. · Lung Cancer · 2020 · 33 citations

, , +7

Loss of STING expression is prognostic in non–small cell lung cancer

Zoltán Lohinai, Dávid Dóra, Charles W. Caldwell et al. · Journal of Surgical Oncology · 2022 · 26 citations · Full text

Rows per page

1–5 of 13